Efficacy and Safety of GMRx2 Compared to Placebo for the Treatment of Hypertension
Condition: Hypertension Interventions: Drug: Telmisartan 10 mg/amlodipine 1.25 mg/indapamide 0.625 mg; Drug: Telmisartan 20 mg/amlodipine 2.5 mg/indapamide 1.25 mg; Drug: Placebo Sponsor: George Medicines PTY Limited Not yet recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials